Section of Gastroenterology and Hepatology.
Houston Methodist Gastroenterology Associates.
J Clin Gastroenterol. 2024;58(5):432-439. doi: 10.1097/MCG.0000000000001890. Epub 2023 Jul 13.
Clinical guidelines reserve endoscopic surveillance after a gastric intestinal metaplasia (GIM) diagnosis for high-risk patients. However, it is unclear how closely guidelines are followed in clinical practice. We examined the effectiveness of a standardized protocol for the management of GIM among gastroenterologists at a US hospital.
This was a preintervention and postintervention study, which included developing a protocol and education of gastroenterologists on GIM management. For the preintervention study, 50 patients with GIM were randomly selected from a histopathology database at the Houston VA Hospital between January 2016 and December 2019. For the postintervention study, we assessed change in GIM management in a cohort of 50 patients with GIM between April 2020 and January 2021 and surveyed 10 gastroenterologists. The durability of the intervention was assessed in a cohort of 50 GIM patients diagnosed between April 2021 and July 2021.
In the preintervention cohort, GIM location was specified (antrum and corpus separated) in 11 patients (22%), and Helicobacter pylori testing was recommended in 11 of 26 patients (42%) without previous testing. Gastric mapping biopsies were recommended in 14% and surveillance endoscopy in 2%. In the postintervention cohort, gastric biopsy location was specified in 45 patients (90%, P <0.001) and H. pylori testing was recommended in 26 of 27 patients without prior testing (96%, P <0.001). Because gastric biopsy location was known in 90% of patients ( P <0.001), gastric mapping was not necessary, and surveillance endoscopy was recommended in 42% ( P <0.001). One year after the intervention, all metrics remained elevated compared with the preintervention cohort.
GIM management guidelines are not consistently followed. A protocol for GIM management and education of gastroenterologists increased adherence to H. pylori testing and GIM surveillance recommendations.
临床指南为高风险患者保留了胃肠上皮化生(GIM)诊断后的内镜监测。然而,目前尚不清楚在临床实践中指南的遵循程度如何。我们研究了美国一家医院的胃肠病学家对 GIM 管理的标准化方案的有效性。
这是一项干预前后研究,包括制定方案和对胃肠病学家进行 GIM 管理教育。在干预前研究中,从 2016 年 1 月至 2019 年 12 月,休斯顿退伍军人事务医院的组织病理学数据库中随机选择了 50 例 GIM 患者。在干预后研究中,我们评估了 2020 年 4 月至 2021 年 1 月期间 GIM 管理在 50 例 GIM 患者中的变化,并对 10 名胃肠病学家进行了调查。在 2021 年 4 月至 2021 年 7 月期间诊断的 50 例 GIM 患者队列中评估了干预的持久性。
在干预前队列中,11 例(22%)患者明确了 GIM 部位(胃窦和胃体分开),26 例(42%)无既往检测的患者建议进行幽门螺杆菌检测。14%的患者建议进行胃活检,2%的患者建议进行内镜监测。在干预后队列中,45 例(90%,P <0.001)患者明确了胃活检部位,27 例无既往检测的患者建议进行 H. pylori 检测(96%,P <0.001)。由于 90%的患者(P <0.001)胃活检部位已知,因此不需要进行胃活检,建议进行内镜监测(42%,P <0.001)。干预一年后,所有指标与干预前队列相比均升高。
GIM 管理指南并未得到一致遵循。GIM 管理方案和对胃肠病学家的教育增加了对 H. pylori 检测和 GIM 监测建议的依从性。